The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells
2019 · Journal of Experimental & Clinical Cancer Research · 50 citations
https://doi.org/10.1186/s13046-019-1195-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
146
Citations
6
h-index
6
i10-index
Feng Lin is an academic researcher from Shanghai Eighth People Hospital. The author has contributed to research in topics: Cancer-related molecular mechanisms research & MicroRNA in disease regulation & RNA Research and Splicing. The author has an h-index of 6, co-authored 12 publications.
ORCID: 0000-0003-3826-0687https://doi.org/10.1186/s13046-019-1195-y
https://doi.org/10.1186/s12885-024-13278-3
Click to start Chat